Cargando…
Outcome of Combined Neoadjuvant Chemotherapy and Vitamin A in Advanced Cervical Carcinoma: A Randomized Double-Blind Clinical Trial
BACKGROUND: The latest World Health Organization (WHO) inquiry on the epidemiology of cervical cancers indicate there are approximately 528,000 new cases per year, ranking fourth after breast, colorectal and lung cancer. The validity of neoadjuvant chemotherapy (NAC) alone in advanced cervical cance...
Autor principal: | Sanusi, Rizal Sanif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745224/ https://www.ncbi.nlm.nih.gov/pubmed/31350987 http://dx.doi.org/10.31557/APJCP.2019.20.7.2213 |
Ejemplares similares
-
Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma
por: Domenge, C, et al.
Publicado: (2000) -
Neoadjuvant chemotherapy for locally advanced cervical cancer
por: Iwata, Takashi, et al.
Publicado: (2016) -
Randomized double-blind trial of beta-carotene and vitamin C in women with minor cervical abnormalities
por: Mackerras, D, et al.
Publicado: (1999) -
Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
por: Sugiyama, T, et al.
Publicado: (1999) -
Effects of neoadjuvant chemotherapy combined with radiotherapy in patients with advanced esophageal carcinoma
por: Liu, Yu, et al.
Publicado: (2017)